Chinese Medical Journal (Sep 2021)

Rechallenge pemetrexed-based chemotherapy provides an option for initially benefited patients with advanced lung adenocarcinoma

  • Jia-Ni Wang,
  • Quan-Hui Qiao,
  • Xing-Sheng Hu,
  • Yu-Tao Liu,
  • Zhi-Jie Wang,
  • Jian-Chun Duan,
  • Yu Feng,
  • Hao-Hua Zhu,
  • Li-Shao Guo

DOI
https://doi.org/10.1097/CM9.0000000000001511
Journal volume & issue
Vol. 134, no. 17
pp. 2119 – 2121

Abstract

Read online

No abstracts available.